About: BAY 59-3074

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals, and has modest affinity for both CB1 and CB2 receptors, with Ki values of 48.3nM at CB1 and 45.5nM at CB2.

Property	Value
dbo:abstract	BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals, and has modest affinity for both CB1 and CB2 receptors, with Ki values of 48.3nM at CB1 and 45.5nM at CB2. (en)
dbo:casNumber	406205-74-1
dbo:fdaUniiCode	5FO5Z101GU
dbo:pubchem	10479060
dbo:thumbnail	wiki-commons:Special:FilePath/BAY59-3074.svg?width=300
dbo:wikiPageID	16567045 (xsd:integer)
dbo:wikiPageLength	2733 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1082421722 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Cannabinoid_receptor dbr:Partial_agonist dbr:Bayer dbc:Cannabinoids dbc:Trifluoromethyl_compounds dbr:Dissociation_constant dbr:Analgesic dbc:Diphenyl_ethers dbc:Resorcinol_ethers dbc:2-Hydroxybenzonitrile_ethers dbc:Phenyl_sulfonate_ethers dbr:Cannabinoid_receptor_1 dbr:Cannabinoid_receptor_2
dbp:c	18 (xsd:integer)
dbp:casNumber	406205 (xsd:integer)
dbp:chemspiderid	8654468 (xsd:integer)
dbp:f	6 (xsd:integer)
dbp:h	13 (xsd:integer)
dbp:iupacName	3 (xsd:integer)
dbp:legalStatus	Unscheduled (en)
dbp:n	1 (xsd:integer)
dbp:o	4 (xsd:integer)
dbp:pubchem	10479060 (xsd:integer)
dbp:s	1 (xsd:integer)
dbp:smiles	FCCCCSOc2ccccc2 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	LWUSZIVDPJPVBW-UHFFFAOYSA-N (en)
dbp:unii	5 (xsd:integer)
dbp:verifiedrevid	461344509 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:width	220 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Cannabinoid-stub dbt:Cannabinoids dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite
dcterms:subject	dbc:Cannabinoids dbc:Trifluoromethyl_compounds dbc:Diphenyl_ethers dbc:Resorcinol_ethers dbc:2-Hydroxybenzonitrile_ethers dbc:Phenyl_sulfonate_ethers
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatNitriles yago:WikicatSulfonateEsters yago:Abstraction100002137 yago:Chemical114806838 yago:Compound114818238 yago:Element114840755 yago:Ester114850483 yago:Material114580897 yago:Matter100020827 yago:Nitrile114827346 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Quintessence114847103 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:WikicatPhenolEthers umbel-rc:DrugProduct
rdfs:comment	BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals, and has modest affinity for both CB1 and CB2 receptors, with Ki values of 48.3nM at CB1 and 45.5nM at CB2. (en)
rdfs:label	BAY 59-3074 (en)
owl:sameAs	freebase:BAY 59-3074 yago-res:BAY 59-3074 wikidata:BAY 59-3074 dbpedia-sh:BAY 59-3074 dbpedia-sr:BAY 59-3074 https://global.dbpedia.org/id/4UryM
prov:wasDerivedFrom	wikipedia-en:BAY_59-3074?oldid=1082421722&ns=0
foaf:depiction	wiki-commons:Special:FilePath/BAY59-3074.svg
foaf:isPrimaryTopicOf	wikipedia-en:BAY_59-3074
is dbo:wikiPageRedirects of	dbr:C18H13F6NO4S
is dbo:wikiPageWikiLink of	dbr:List_of_psychedelic_drugs dbr:C18H13F6NO4S
is foaf:primaryTopic of	wikipedia-en:BAY_59-3074